MAP2K5 and breast cancer: STAT3 upregulation decreased the epithelial marker E-cadherin and increased mesenchymal markers vimentin, SNAIL, SLUG, and ZEB and cell migration and invasion via the MEKK2/3-MEK5-ERK5 signaling axis in breast cancer cells [57].